KRAS Testing and Its Importance in Colorectal Cancer
KRAS Testing and Its Importance in Colorectal Cancer
About this item
Full title
Author / Creator
Publisher
New York: Current Science Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Current Science Inc
Subjects
More information
Scope and Contents
Contents
Cetuximab and panitumumab are monoclonal antibodies used in the treatment of metastatic colorectal cancer (mCRC) by selectively targeting the epidermal growth factor receptor (EGFR) axis. Studies have shown that mutations in codons 12/13 of exon 2 of the KRAS gene render these therapies ineffective. As a result, the National Comprehensive Cancer Ne...
Alternative Titles
Full title
KRAS Testing and Its Importance in Colorectal Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733924095
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733924095
Other Identifiers
ISSN
1523-3790
E-ISSN
1534-6269
DOI
10.1007/s11912-010-0099-y
